+987.9%
MRNA vs SPXS
-30.2%
+1,018.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPXS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -4.9% | +18.0% | +9.1% |
| 7D | +20.6% | +2.2% | +18.5% | +23.2% |
| 30D | +27.1% | +3.8% | +23.4% | +32.6% |
| 3M | +353.4% | +3.3% | +350.1% | +378.7% |
| 6M | +446.3% | -16.7% | +462.9% | +414.7% |
| YTD | +776.2% | -28.5% | +804.7% | +665.4% |
| 1Y | +987.9% | -30.4% | +1,018.4% | +841.6% |
| All | +987.9% | -30.2% | +1,018.1% | +841.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXS.
Daily Out/Under-Performance
Portfolio return minus SPXS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPXS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling